|
|
| Line 1: |
Line 1: |
| {| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0";
| | __NOTOC__ |
| ! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Ramipril|{{fontcolor|#6C7B8B|Ramipril}}]]'''''
| | {{SB}} ALTACE<sup>®</sup> Prilace<sup>®</sup> Ramipro<sup>®</sup> Tritace<sup>®</sup> Altace<sup>®</sup> Ramitens<sup>®</sup> Ampril<sup>®</sup> Corpril<sup>®</sup> Piramil<sup>®</sup> Prilinda<sup>®</sup> Ramace<sup>®</sup> Altace<sup>®</sup> <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ALTACE (RAMIPRIL) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0fc34cd8-86e6-4034-73bd-4263a68ba046 | publisher = | date = | accessdate = }}</ref> |
| |-
| | {{Ramipril}} |
| ! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | ALTACE<sup>®</sup> FDA Package Insert
| | |
| |-
| | ==References== |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ramipril indications and usage|Indications and Usage]]
| | |
| |-
| | {{Reflist|2}} |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ramipril dosage and administration|Dosage and Administration]]
| | |
| |- | | [[Category:Cardiovascular Drugs]] |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ramipril contraindications|Contraindications]]
| | [[Category:Drugs]] |
| |-
| |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ramipril warnings and precautions|Warnings and Precautions]]
| |
| |-
| |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ramipril adverse reactions|Adverse Reactions]]
| |
| |- | |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ramipril drug interactions|Drug Interactions]]
| |
| |-
| |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ramipril use in specific populations|Use in Specific Populations]]
| |
| |-
| |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ramipril overdosage|Overdosage]]
| |
| |-
| |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ramipril description|Description]]
| |
| |-
| |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ramipril clinical pharmacology|Clinical Pharmacology]]
| |
| |-
| |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ramipril clinical studies|Clinical Studies]]
| |
| |-
| |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ramipril how supplied storage and handling|How Supplied/Storage and Handling]]
| |
| |-
| |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ramipril patient counseling information|Patient Counseling Information]]
| |
| |-
| |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ramipril labels and packages|Labels and Packages]]
| |
| |-
| |
| ! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Clinical Trials on Ramipril
| |
| |-
| |
| ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [http://clinicaltrials.gov/search/open/condition={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} ClinicalTrials.gov]
| |
| |-
| |
| |}
| |
Synonyms / Brand Names: ALTACE® Prilace® Ramipro® Tritace® Altace® Ramitens® Ampril® Corpril® Piramil® Prilinda® Ramace® Altace® [1]
Synonyms / Brand Names: ALTACE® Prilace® Ramipro® Tritace® Altace® Ramitens® Ampril® Corpril® Piramil® Prilinda® Ramace® Altace® [1]
Template loop detected: Template:Ramipril
References
References